Expert Perspectives

Andrew Alexis, MD, MPH; Karan Lal, DO, MS, FAAD; James Song, MD; Lisa Swanson, MD, and Lisa Swanson, MD, address vitiligo management across adult and pediatric populations, examining treatment strategies, psychological support, emerging therapies like JAK inhibitors, and the critical importance of individualized care plans that consider disease characteristics, age-specific needs, and family education.

Aaron Farberg, MD, discusses how red light therapy’s diverse applications in wound healing and aesthetic dermatology offer a noninvasive treatment option with promising outcomes across various medical and cosmetic fields.

Five experts delve into the multifaceted aspects of pediatric atopic dermatitis care including demographic variances to long-term safety and efficacy, comparative analyses, key takeaways from recent research, personalized approaches, and future research directions. Discover clinical insights into the role of ruxolitinib in addressing critical challenges and enhancing patient outcomes.

This series delves into the multifaceted landscape of atopic dermatitis (AD) care and treatment. Through interviews with 4 leading dermatologists, this series explores key benchmarks, emerging trends, personalized medicine approaches, long-term safety considerations, and the integration of novel therapies in the management of AD.

An expert in dermatology introduces a video series program exploring cutting-edge treatments at the forefront of atopic dermatitis management, exploring innovative insights and research that will redefine dermatological care.

Experts in dermatology discuss key highlights, updates, and take-aways from the 2023 Science of Skincare Summit.

Experts in dermatology discuss hot topics in skin care from AAD 2023 relating to skin renewal, photoprotection in patients with skin of color, next generation cleansing technologies, and the use of over the counter and prescription acne products.

Experts in dermatology discuss the practical and clinical considerations in the management of Generalized Pustular Psoriasis; highlighting a recent treatment approval.